AI
The company will use the funds to try and level the playing field between payers and providers.
The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.
They will collaborate on identifying novel therapeutic drug candidates for lung cancer.
The collaboration aims to foster innovation, commercialization and adoption of AI in imaging.
This marks AITRICS's first foray into Southeast Asia, with applications for regulatory clearance in Indonesia and Malaysia underway.
Cardio Intelligence is now testing its latest AI for detecting paroxysmal atrial fibrillation.
The project aims to promote AI-powered tech support for care providers and help streamline administrative tasks while boosting clinical decision-making.
Peak body RACGP has recently released its guidance for adopting the technology.
It has also received Australia's regulatory approval for its AI solution.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.